Activate Now
ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help

Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Brain White Matter Abnormalities in Female Interstitial Cystitis/Bladder Pain Syndrome: A MAPP Netwo...

How One LLND Treats Lyme disease and Co-infections Using Natural Medicine

Lyme Camp- A Unique Event for People with Lyme Disease

International Lyme and Associated Diseases Society Hosts Its Annual Scientific Conference in Ft. Lau...

Acupuncture reduces hot flashes in breast cancer survivors

Why Does Your Stomach Growl?

Top 7 Nutrient-Dense Foods That Make Calorie Counting Obsolete

For veterans with Gulf War Illness, an explanation for the unexplainable symptoms

Magnificent Milk Thistle

DePaul Study Recruiting Participants

Print Page
Email Article

Potent, Non-Addictive New Pain Drug as Little as One Year from Market

  [ 28 votes ]   [ 3 Comments ] • January 30, 2011

“The potential for such drugs is enormous – the reduction or elimination of pain for patients with cancer, arthritis, migraine headaches, muscle pain, pain from burns, and pain from other debilitating diseases.”

A powerful new painkiller, which in effect keeps pain signals from being transmitted rather than dulling their perception, may now reach market in as little as a year, after decades of work.

Developed on the basis of research conducted at New York’s Stony Brook University,(1) the drug has no apparent side effects or addictive qualities, according to Dr. Simon Halegoua, PhD, Professor of Neurobiology & Behavior at Stony Brook.

"This offers a major paradigm shift in the control of pain," declares Dr. Halegoua, who in the 1990s teamed up with fellow Stony Brook professors Dr. Gail Mandel and Dr. Paul Brehm to identify a novel sodium ion channel involved in the transmission of pain.

They predicted that a drug aimed at blocking this channel, PN1/Nav 1.7, would control pain.

PN1 (Peripheral Neuron 1), is uniquely expressed in peripheral nerves such as those involved in pain transduction.

"When a patient is given an opiate like morphine, pain signals are still transmitted from sensory nerves to the central nervous system,” Dr. Halegoua explains. “Morphine action throughout the brain reduces and alters pain perception, but it also impairs judgment and results in drug dependence."

But "With drugs targeting the PN1/Nav1.7 sodium ion channel, the pain signals would not be transmitted, even by the sensory nerves. And since the central nervous system is taken out of the equation, there would be no side effects and no addictive qualities."

The potential for such drugs is enormous – the reduction or elimination of pain for patients with cancer, arthritis, migraine headaches, muscle pain, pain from burns, and pain from other debilitating diseases.

Dr. Halegoua notes that:

Drugs in both oral and topical ointment forms, based on the research he conducted in a basement laboratory at Stony Brook with Dr. Mandel, a molecular biologist, and Dr. Brehm, an electrophysiologist, are currently in Phase II clinical trials in England and Canada. 

• The Research Foundation of the State University of New York is the holder of the various patents originating from the work of the Stony Brook researchers.

• Icagen Inc., now in partnership with Pfizer, holds the exclusive license to these patents and has announced their own drug has now entered Phase I clinical trials in the U.S. [See the news release dated Dec 20, 2010 - “Icagen and Pfizer Initiate Phase 1 Trial in Nav1.7 Program”. Icagen is based in Research Triangle Park, North Carolina.]

1. “The Search to End Pain Takes a New Direction as Stony Brook Research Prompts New Interest.” (“Recent Discovery of Pain Free Children Harkens Back to 90’s Study.")

Source: Stony Brook University news release, Jan 25, 2011

Please Discuss This Article:   Post a Comment 

Non-Addictive Pain Killer scary
Posted by: Celia2000
Feb 2, 2011
Completely blocking pain perception may sound great, however, if you are taking the drug for one reason, and then do something that would ordinarily result in pain (a good thing - reminds you to be careful) you wouldn't even know something was wrong!
Reply Reply

I agree - scary
Posted by: AuntTammie
Feb 2, 2011
That drug is basically replicating leprosy.....People with leprosy were not sick so much from having the illness itself but from the effects of not being able to feel pain. Blocking one source of pain is one thing, but blocking all sensation of it is dangerous.
Reply Reply

Posted by: emmanuelle
Feb 10, 2011
I think the other two commenters misunderstood what the drug would do. They're talking about blocking pain in already existing conditions-- not replicating Leprosy. I'd wager that anyone who finds the idea of this drug "scary" is not suffering from chronic pain! I'm a big fan of supplements and herbs as a first line of defense; but if you have chronic pain and would rather not take opiates, this drug would be a real Godsend! Thank you, ProHealth for keeping us posted on news such as this.
Reply Reply

Post a Comment

Free Chronic Fatigue Syndrome and Fibromyalgia Newsletters
Subscribe to
Subscribe Now!
Receive up-to-date ME/CFS, Fibromyalgia & Lyme Disease treatment and research news
 Privacy Guaranteed  |  View Archives

Vitamins and Supplements

Featured Products

FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils

Natural Remedies

Running on Empty? Fuel Up with NADH Running on Empty? Fuel Up with NADH
SAM-e: a Hard-Working Molecule that May Help Ease Pain & Brighten Mood SAM-e: a Hard-Working Molecule that May Help Ease Pain & Brighten Mood
Anti-Inflammatory Properties of Tart Cherry Anti-Inflammatory Properties of Tart Cherry
Carry a Massage Therapist in Your Pocket Carry a Massage Therapist in Your Pocket
Cell-Charging Compound Gives Steady Energy to Fibromyalgia & Chronic Fatigue Patients Cell-Charging Compound Gives Steady Energy to Fibromyalgia & Chronic Fatigue Patients

What is Fibromyalgia?
Fibromyalgia Diagnosis
Fibromyalgia Symptoms
Fibromyalgia Causes
Fibromyalgia Treatments
Fibromyalgia Diet
Fibromyalgia Medications
M.E. & CFS
What is M.E./CFS?
M.E./CFS Diagnosis
M.E./CFS Symptoms
M.E./CFS Causes
M.E./CFS Treatments
M.E./CFS Diet
M.E./CFS Medications
What is Lyme Disease?
Lyme Disease Diagnosis
Lyme Disease Symptoms
Lyme Disease Causes
Lyme Disease Treatments
Lyme Disease Diet
Lyme Disease Medications
M.E. & CFS
Lyme Disease
General Health
ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus
Credit Card Processing